Poultry Science,
Год журнала:
2024,
Номер
103(4), С. 103482 - 103482
Опубликована: Янв. 25, 2024
Fatty
liver
hemorrhagic
syndrome
(FLHS)
is
a
prevalent
metabolic
disorder
observed
in
egg-laying
hens,
characterized
by
fatty
deposits
and
cellular
steatosis
the
liver.
Our
preliminary
investigations
have
revealed
marked
decrease
concentration
of
butyric
acid
FLHS
strain
laying
hens.
It
has
been
established
that
sodium
butyrate
(NaB)
protects
against
disorders.
However,
underlying
mechanism
which
modulates
hepato-lipid
metabolism
to
great
extent
remains
unexplored.
In
this
study,
we
constructed
an
isolated
vitro
model
chicken
primary
hepatocytes
induce
hepatic
free
acids
(FFA).
results
demonstrate
treatment
with
NaB
effectively
mitigated
FFA-induced
inhibiting
lipid
accumulation,
downregulating
mRNA
expression
lipo-synthesis-related
genes
(sterol
regulatory
element
binding
transcription
factor
1
(SREBF1),
acetyl-CoA
carboxylase
1(ACC1),
synthase
(FASN),
stearoyl-CoA
desaturase
(SCD1),
X
receptor
α
(LXRα),
3-hydroxy-3-methylglutaryl-CoA
reductase
(HMGR))
(P
<
0.05),
upregulating
protein
AMP-activated
kinase
α1
(AMPKα1),
peroxisome
proliferator-activated
(PPARα),
carnitine
palmitoyl-transferase
1A
(CPT1A)
0.05).
Moreover,
AMPK
PPARα
inhibitors
(Compound
C
(Comp
C)
GW6471,
respectively)
reversed
protective
effects
blocking
AMPK/PPARα
pathway,
leading
droplet
accumulation
triglyceride
(TG)
contents
hepatocytes.
With
these
findings,
can
alleviate
hepatocyte
lipoatrophy
injury
activating
promoting
oxidation,
reducing
synthesis
hepatocytes,
potentially
being
able
provide
new
ideas
for
FLHS.
Hepatocellular
carcinoma
(HCC)
is
a
heterogeneous
tumor
associated
with
several
risk
factors,
non-alcoholic
fatty
liver
disease
(NAFLD)
emerging
as
an
important
cause
of
tumorigenesis.
Due
to
the
obesity
epidemics,
occurrence
NAFLD
has
significantly
increased
nearly
30%
prevalence
worldwide.
HCC
often
arises
in
background
chronic
(CLD),
such
nonalcoholic
steatohepatitis
(NASH)
and
cirrhosis.
Gut
microbiome
(GM)
alterations
have
been
linked
progression
development,
investigations
reporting
crucial
role
for
gut-liver
axis
microbial
metabolites
promoting
CLD.
Moreover,
GM
affects
homeostasis,
energy
status,
immune
microenvironment,
influencing
response
immunotherapy
interesting
therapeutic
implications.
In
this
review,
we
summarize
main
changes
derived
(e.g.,
short-chain
acids
bile
acids)
occurring
patients
progression,
emphasizing
their
potential
early
diagnostic
biomarkers
prognostic
tools.
We
discuss
weight
loss
effects
diet-based
interventions
healthy
lifestyles
treatment
patients,
highlighting
impact
on
restoration
intestinal
barrier
structure.
also
describe
encouraging
preclinical
findings
modulation
improve
functions
CLD,
boost
antitumor
probiotic
supplementations
or
anti-hypercholesterolemic
drug
treatment),
ultimately
delay
HCC.
The
development
safe
effective
strategies
that
target
holds
promise
cancer
prevention
treatment,
especially
if
personalized
options
will
be
considered.
Medicina,
Год журнала:
2025,
Номер
61(2), С. 192 - 192
Опубликована: Янв. 22, 2025
The
purpose
of
this
article
is
to
present
selected
food
additives
as
disruptors
normal
intestinal
homeostasis
with
a
potential
impact
on
the
development
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD).
A
comprehensive
literature
search
was
conducted
in
three
major
electronic
databases:
PubMed,
ScienceDirect,
and
Google
Scholar.
MASLD
prevalent
condition
that
closely
related
global
rise
obesity.
Its
pathogenesis
multifactorial,
genetic,
environmental,
factors
playing
key
role.
“multiple-hit”
hypothesis
suggests
Western-style
diet,
rich
ultra-processed
foods,
saturated
fats,
additives,
combined
low
physical
activity,
contributes
obesity,
which
promotes
lipid
accumulation
liver.
Recent
studies
underscore
role
impaired
MASLD.
Food
including
preservatives,
emulsifiers,
sweeteners,
affect
gut
health
function.
Selected
preservatives
inhibit
pathogenic
microorganisms
but
disrupt
microbiota,
leading
changes
permeability
dysfunction.
Some
emulsifiers
thickeners
can
cause
inflammation
alter
microbiome,
contributing
steatosis.
Furthermore,
use
sweeteners
such
sucralose
aspartame
has
been
linked
metabolism
microbial
composition,
turn
disorders.
Microorganisms,
Год журнала:
2022,
Номер
11(1), С. 95 - 95
Опубликована: Дек. 30, 2022
This
review
aims
to
bring
a
more
general
view
of
the
technological
and
biological
challenges
regarding
production
use
probiotic
bacteria
in
promoting
human
health.
After
brief
description
current
concepts,
for
at
an
industrial
level
are
presented
from
physiology
central
metabolism
ability
face
main
forms
stress
process.
Once
produced,
these
cells
processed
be
commercialized
suspension
or
dried
added
food
matrices.
At
this
stage,
maintenance
cell
viability
vitality
is
paramount
quality
product.
Powder
products
requires
development
strategies
that
ensure
integrity
components
cellular
functions
allow
complete
recovery
time
consumption.
Finally,
once
consumed,
must
very
powerful
set
physicochemical
mechanisms
within
body,
which
include
enzymes,
antibacterial
molecules
sudden
changes
pH.
Understanding
action
agents
induction
tolerance
fundamental
selection
increasingly
efficient
strains
order
survive
colonization
intestinal
tract
promote
desired
health
benefits.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(19), С. 14918 - 14918
Опубликована: Окт. 5, 2023
Alterations
in
the
gut–liver
axis
and
changes
gut
microbiome
are
among
risk
factors
for
pathogenesis
of
non-alcoholic
fatty
liver
disease
(NAFLD).
These
patients
show
increased
bacterial
overgrowth
small
intestine
impaired
intestinal
permeability.
Therefore,
therapeutic
options
such
as
probiotics
or
prebiotics
have
been
investigated
to
modulate
microbiota
composition
improve
NAFLD.
Most
vivo
vitro
probiotic
studies
focused
on
reducing
hepatic
fat
accumulation.
The
beneficial
effects
NAFLD
demonstrated
animal
models,
most
widely
used
microorganisms
those
Lactobacillus
Bifidobacterium
genera.
In
help
restore
integrity
barrier.
This
narrative
review
summarizes
published
evidence
likely
benefits
a
option
with
Nutrients,
Год журнала:
2023,
Номер
15(17), С. 3722 - 3722
Опубликована: Авг. 25, 2023
Metabolic
(dysfunction)
associated
fatty
liver
disease
(MAFLD)
is
recognized
as
the
most
prevalent
chronic
globally.
However,
its
pathogenesis
remains
incompletely
understood.
Recent
advancements
in
gut-liver
axis
offer
novel
insights
into
development
of
MAFLD.
Polysaccharides,
primarily
derived
from
fungal
and
algal
sources,
abundantly
exist
human
diet
exert
beneficial
effects
on
glycometabolism,
lipid
metabolism,
inflammation,
immune
modulation,
oxidative
stress,
release
Numerous
studies
have
demonstrated
that
these
bioactivities
polysaccharides
are
with
their
prebiotic
properties,
including
ability
to
modulate
gut
microbiome
profile,
maintain
barrier
integrity,
regulate
metabolites
produced
by
microbiota
such
lipopolysaccharide
(LPS),
short-chain
acids
(SCFAs),
bile
(BAs),
contribute
intestinal
homeostasis.
This
narrative
review
aims
present
a
comprehensive
summary
current
understanding
protective
MAFLD
through
interactions
metabolites.
Specifically,
we
highlight
potential
molecular
mechanisms
underlying
polysaccharides,
which
may
give
new
avenues
for
prevention
treatment
Frontiers in Cellular and Infection Microbiology,
Год журнала:
2023,
Номер
13
Опубликована: Авг. 9, 2023
Introduction
Recently
the
role
of
gut
microbial
dysbiosis
in
many
ocular
disorders,
including
but
not
limited
to
uveitis,
age-related
macular
degeneration
(AMD),
diabetic
retinopathy
(DR),
dry
eye,
keratitis
and
orbitopathy
is
a
hot
research
topic
field.
Targeting
microbiota
treat
these
diseases
has
become
an
unstoppable
trend.
Bibliometric
study
visualization
analysis
have
essential
methods
for
literature
medical
We
aim
depict
this
area's
hotspots
future
directions
by
bibliometric
software
methods.
Methods
search
all
related
publications
from
Web
Science
Core
Collection.
Then,
CiteSpace
was
applied
analyze
visualize
country
distributions,
dual-map
overlay
journals,
keyword
bursts,
co-cited
references.
VOSviewer
employed
identify
authors,
journals
display
co-occurrence
networks.
Results
A
total
284
relevant
were
identified
2009
2023.
The
number
studies
been
small
first
five
years
grown
steadily
since
2016.
These
completed
1,376
authors
41
countries
worldwide,
with
United
States
lead.
Lin
P
published
most
papers
while
Horai
R
author.
top
journal
are
both
Investigative
Ophthalmology
&
Visual
Science.
In
network,
except
microbiota,
inflammation
becomes
highest
frequency.
Co-citation
analyses
reveal
that
involved
common
immune-
inflammation-mediated
eye
diseases,
retinopathy,
degeneration,
Graves'
orbitopathy,
microbiomes
no
longer
bacterial
populations.
Therapeutic
strategies
target
such
as
probiotics,
healthy
diet
patterns,
fecal
transplantation,
effective
critical
research.
Conclusions
conclusion,
displays
developmental
involvement
pathogenesis
treatment
some
diseases.
It
provides
overview
field's
dynamic
evolution
structural
relationships.